Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Kingham

Showing results (361-370 of 465) with videos related to

Pageof 47
Sort By:
Annals of Surgical Oncology|January 28, 2025
Robotic Versus Open Placement of Hepatic Artery Infusion PumpsLauren E Schleimer, Annie Liu, Hannah L Kalvin, et al.
JAMA Surgery|May 22, 2024
Hemorrhage Sites and Mitigation Strategies After PancreaticoduodenectomyWilliam A Preston, Micaela L Collins, Mithat Gönen, et al.
Annals of Surgery|June 6, 2014
A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinomaEileen M OʼReilly, Anna Perelshteyn, William R Jarnagin, et al.
Annals of Surgical Oncology|October 9, 2023
Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic CholangiocarcinomaStijn Franssen, Jessica J Holster, Joshua S Jolissaint, et al.
Journal of Medical Imaging (Bellingham, Wash.)|July 3, 2020
Multimodal radiomics and cyst fluid inflammatory markers model to predict preoperative risk in intraductal papillary mucinous neoplasmsKate A Harrington, Travis L Williams, Sharon A Lawrence, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2018
Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune TherapiesJames J Harding, Subhiksha Nandakumar, Joshua Armenia, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 9, 2025
Comparison of intraoperative and postoperative metrics in robotic vs. laparoscopic liver resections by difficulty - Retrospective cohort analysis of a multi-institutional databaseMichael J Lee, Amir Ashraf Ganjouei, Jane Wang, et al.
Annals of Surgery|December 6, 2019
Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?: Results from a Multi-institutional StudyAlessandra Pulvirenti, Georgios A Margonis, Vicente Morales-Oyarvide, et al.
Cancer|June 24, 2020
Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinomaCaitlin A McIntyre, Sharon A Lawrence, Allison L Richards, et al.
Annals of Surgery|January 13, 2017
Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery ConsortiumMarc A Attiyeh, Carlos Fernández-Del Castillo, Mohammad Al Efishat, et al.
Pageof 47

Showing results (361-370 of 465) with videos related to

Sort By:
Pageof 47
Annals of Surgical Oncology|January 28, 2025
Robotic Versus Open Placement of Hepatic Artery Infusion PumpsLauren E Schleimer, Annie Liu, Hannah L Kalvin, et al.
JAMA Surgery|May 22, 2024
Hemorrhage Sites and Mitigation Strategies After PancreaticoduodenectomyWilliam A Preston, Micaela L Collins, Mithat Gönen, et al.
Annals of Surgery|June 6, 2014
A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinomaEileen M OʼReilly, Anna Perelshteyn, William R Jarnagin, et al.
Annals of Surgical Oncology|October 9, 2023
Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic CholangiocarcinomaStijn Franssen, Jessica J Holster, Joshua S Jolissaint, et al.
Journal of Medical Imaging (Bellingham, Wash.)|July 3, 2020
Multimodal radiomics and cyst fluid inflammatory markers model to predict preoperative risk in intraductal papillary mucinous neoplasmsKate A Harrington, Travis L Williams, Sharon A Lawrence, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2018
Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune TherapiesJames J Harding, Subhiksha Nandakumar, Joshua Armenia, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 9, 2025
Comparison of intraoperative and postoperative metrics in robotic vs. laparoscopic liver resections by difficulty - Retrospective cohort analysis of a multi-institutional databaseMichael J Lee, Amir Ashraf Ganjouei, Jane Wang, et al.
Annals of Surgery|December 6, 2019
Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?: Results from a Multi-institutional StudyAlessandra Pulvirenti, Georgios A Margonis, Vicente Morales-Oyarvide, et al.
Cancer|June 24, 2020
Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinomaCaitlin A McIntyre, Sharon A Lawrence, Allison L Richards, et al.
Annals of Surgery|January 13, 2017
Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery ConsortiumMarc A Attiyeh, Carlos Fernández-Del Castillo, Mohammad Al Efishat, et al.
Pageof 47